Megan D. Maerz

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Fewer LAG-3+ T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes”.

Fewer LAG-3+ T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes

The Journal of Immunology(2022)10.4049/jimmunol.2100850

N/A

0DataRank · unranked

32 citations

Megan D. Maerz, Henry T. Bahnson, Ashwin Somasundaram, Lucas McCarthy, Cate Speake +2 more

IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function

JCI Insight(2022)10.1172/jci.insight.159436

N/A

0DataRank · unranked

21 citations

Tania Habib, Katharina Lambert, Christian Hundhausen, Sandra Lord, Matthew J. Dufort +11 more

IL-6-Driven pSTAT1 Response Is Linked to T Cell Features Implicated in Early Immune Dysregulation

Frontiers in Immunology(2022)10.3389/fimmu.2022.935394

N/A

0DataRank · unranked

8 citations

Kirsten E. Diggins, Britta E. Jones, Christian Hundhausen, Megan D. Maerz, Anne M. Hocking +6 more

Functional and biological implications of clonotypic diversity among human donor‐unrestricted T cells

Immunology and Cell Biology(2024)10.1111/imcb.12751

N/A

0DataRank · unranked

1 citations

Deborah L Cross, Chetan Seshadri, Megan D. Maerz